BAMCO Inc
ADMS

BAMCO Inc’s Adamas Pharmaceuticals ADMS Stock Holding History

BAMCO Inc’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-78,200
Closed -$1.57M – 394
2018
Q3 		$1.57M Sell
78,200
-131,984
-63% -$3.1M 0.01% 296
2018
Q2 		$5.43M Sell
210,184
-12,382
-6% -$343K 0.02% 228
2018
Q1 		$5.32M Buy
222,566
+99,366
+81% +$3.13M 0.02% 226
2017
Q4 		$4.17M Buy
123,200
+20,000
+19% +$558K 0.02% 250
2017
Q3 		$2.19M Hold
103,200
– – 0.01% 270
2017
Q2 		$1.8M Buy
103,200
+32,272
+45% +$534K 0.01% 275
2017
Q1 		$1.24M Buy
70,928
+31,928
+82% +$544K 0.01% 292
2016
Q4 		$659K Buy
39,000
+24,500
+169% +$379K ﹤0.01% 298
2016
Q3 		$238K Buy
+14,500
New +$220K ﹤0.01% 297

Other funds holding ADMS

Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BC
Broadfin Capital New York $403M AUM 100.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return